The CD&A narrative is the committee’s opportunity to explain how executive pay reflects oversight, discipline, and strategy.

Using holding power as a strategic indicator of the compensation program’s health can ensure that it truly supports retention and long-term shareholder value creation.

The new methodology underscores a continued shift in pay governance – and places early-stage life sciences companies in a difficult position.

Ignoring a tech company’s unique business model can misalign incentives, weaken shareholder value, and drive talent away.

Highlights and data from the bi-annual survey on bank directors’ compensation levels and practices.

A well-crafted STI plan is a powerful tool for focusing leadership attention, reinforcing strategic priorities, and translating operational performance into pay outcomes.

Analysis for compensation committee members of key findings and unexpected developments from the most recent proxy season.

Insights from Pearl Meyer’s Cyber Security, AI, Robotics and Data Science Salary Survey

As the executive protection landscape evolves, boards should take a proactive, measured, and transparent approach to CEO security.

Using holding power as a strategic indicator of the compensation program’s health can ensure that it truly supports retention and long-term shareholder value creation.

DC Circuit Ends Multiyear Dispute in Favor of Proxy Advisors While Texas Enacts State-Level Proxy Advisor Regulation

Engaging with the board of directors effectively is always a critical responsibility for CEOs, but in the life sciences sector it can be particularly challenging.